We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

12 hedge funds and large institutions have $254K invested in Genetic Technologies Ltd. in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,250% more call options, than puts

Call options by funds: $47K | Put options by funds: $2K

0% more funds holding

Funds holding: 12 → 12 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

4% less capital invested

Capital invested by funds: $265K → $254K (-$10.6K)

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
–
Closed
4
Calls
$47K
Puts
$2K
Net Calls
+$45K
Net Calls Change
-$261K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$36.7K
2
Citadel Advisors
Citadel Advisors
Florida
+$34.9K
3
GSC
Ground Swell Capital
South Carolina
+$32.8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$27.2K
5
Millennium Management
Millennium Management
New York
+$21.9K

Top Sellers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
-$49K
2
VF
Virtu Financial
New York
-$20K
3
Simplex Trading
Simplex Trading
Illinois
-$2.58K
4
PFS
Prospera Financial Services
Texas
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$61K +$36.7K +5,080 +94%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$59K +$27.2K +3,762 +57%
Citadel Advisors
3
Citadel Advisors
Florida
$41K +$34.9K +4,831 +202%
GSC
4
Ground Swell Capital
South Carolina
$26K +$32.8K +4,533 New
CA
5
Cetera Advisors
Colorado
$20K +$4.34K +600 +21%
Millennium Management
6
Millennium Management
New York
$17K +$21.9K +3,025 New
TSS
7
Two Sigma Securities
New York
$14K +$16.9K +2,336 New
UBS Group
8
UBS Group
Switzerland
$8K +$2.51K +347 +34%
CAPTRUST Financial Advisors
9
CAPTRUST Financial Advisors
North Carolina
$4K – – –
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.32K – – –
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$1K +$1.43K +198 +9,900%
Wells Fargo
12
Wells Fargo
California
$1K +$1.45K +200 New
CS
13
Credit Suisse
Switzerland
– -$49K -5,000 Closed
VF
14
Virtu Financial
New York
– -$20K -2,062 Closed
Simplex Trading
15
Simplex Trading
Illinois
– -$2.58K -357 Closed
PFS
16
Prospera Financial Services
Texas
– -$1K -100 Closed

GENE Hedge Fund Activity: Q2 2022 in Review

12 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2022, worth a combined $254K — down 4% from $265K a quarter earlier.

Fund positioning in GENE was balanced in Q2 2022: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $36.7K. The largest seller was Credit Suisse, exiting entirely with an estimated $49K sold.

  • 12 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $254K of Genetic Technologies Ltd. stock for Q2 2022, down 4% quarter-over-quarter.
  • 4 funds opened new Genetic Technologies Ltd. positions in Q2 2022 and 4 closed out, a net change of 0 holders.
  • The largest Genetic Technologies Ltd. buyer in Q2 2022 was Morgan Stanley, an estimated $36.7K added.
  • The largest Genetic Technologies Ltd. seller in Q2 2022 was Credit Suisse, an estimated $49K sold.

Based on aggregated 13F filings for Q2 2022.